BioLife Financial Statements From 2010 to 2025
| BLFS Stock | USD 22.68 2.04 9.88% |
Check BioLife Solutions financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BioLife Solutions' main balance sheet or income statement drivers, such as , as well as many indicators such as . BioLife financial statements analysis is a perfect complement when working with BioLife Solutions Valuation or Volatility modules.
Check out the analysis of BioLife Solutions Correlation against competitors. BioLife Solutions Company Operating Margin Analysis
BioLife Solutions' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current BioLife Solutions Operating Margin | (0.05) % |
Most of BioLife Solutions' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioLife Solutions is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, BioLife Solutions has an Operating Margin of -0.0509%. This is 99.85% lower than that of the Health Care Equipment & Supplies sector and 98.91% lower than that of the Health Care industry. The operating margin for all United States stocks is 99.08% lower than that of the firm.
BioLife Solutions Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioLife Solutions's current stock value. Our valuation model uses many indicators to compare BioLife Solutions value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioLife Solutions competition to find correlations between indicators driving BioLife Solutions's intrinsic value. More Info.BioLife Solutions is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value BioLife Solutions by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About BioLife Solutions Financial Statements
BioLife Solutions shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although BioLife Solutions investors may analyze each financial statement separately, they are all interrelated. The changes in BioLife Solutions' assets and liabilities, for example, are also reflected in the revenues and expenses on on BioLife Solutions' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.